<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034512466413</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034512466413</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Biological</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Effects of C-type Natriuretic Peptide on Craniofacial Skeletogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nakao</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512466413">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Okubo</surname><given-names>Y.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512466413">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yasoda</surname><given-names>A.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512466413">2</xref>
<xref ref-type="corresp" rid="corresp1-0022034512466413">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Koyama</surname><given-names>N.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512466413">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Osawa</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512466413">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Isobe</surname><given-names>Y.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512466413">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kondo</surname><given-names>E.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512466413">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fujii</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512466413">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Miura</surname><given-names>M.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512466413">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nakao</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512466413">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bessho</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512466413">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034512466413"><label>1</label>Department of Oral and Maxillofacial Surgery</aff>
<aff id="aff2-0022034512466413"><label>2</label>Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan</aff>
<author-notes>
<corresp id="corresp1-0022034512466413"><label>*</label><email>yasoda@kuhp.kyoto-u.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>92</volume>
<issue>1</issue>
<fpage>58</fpage>
<lpage>64</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>7</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>9</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>9</day>
<month>10</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2013 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>C-type natriuretic peptide (CNP) is a potent stimulator of long bone and vertebral development <italic>via</italic> endochondral ossification. In the present study, we investigated the effects of CNP on craniofacial skeletogenesis, which consists of both endochondral and membranous ossification. Morphometric analyses of crania from CNP knockout and transgenic mice revealed that CNP stimulates longitudinal growth along the cranial length, but does not regulate cranial width. CNP markedly increased the length of spheno-occipital synchondrosis in fetal murine organ cultures, and the thickness of cultured murine chondrocytes from the spheno-occipital synchondrosis or nasal septum, resulting in the stimulation of longitudinal cranial growth. Mandibular growth includes endochondral and membranous ossification; although CNP stimulated endochondral bone growth of condylar cartilage in cultured fetal murine mandibles, differences in the lengths of the lower jaw between CNP knockout or transgenic mice and wild-type mice were smaller than those observed for the lengths of the upper jaw. These results indicate that CNP primarily stimulates endochondral ossification in the craniofacial region and is crucial for midfacial skeletogenesis.</p>
</abstract>
<kwd-group>
<kwd>chondrocyte(s)</kwd>
<kwd>maxillofacial surgery</kwd>
<kwd>craniofacial anomalies</kwd>
<kwd>craniofacial biology/genetics</kwd>
<kwd>growth factor(s)</kwd>
<kwd>growth/development</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034512466413" sec-type="intro">
<title>Introduction</title>
<p>Mammalian skeletons are formed through intramembranous or endochondral ossification. The former occurs when mesenchymal precursor cells directly differentiate into bone-forming osteoblasts, whereas in the latter process, mesenchymal cells differentiate into chondrocytes and form a cartilage anlage, which is eventually remodeled into calcified bone (<xref ref-type="bibr" rid="bibr5-0022034512466413">Lenton <italic>et al.</italic>, 2011</xref>). Although most mammalian bones are formed through endochondral ossification, the craniofacial skeleton contains bones that develop through either intramembranous or endochondral ossification; bones of the face and cranial vault are thought to develop <italic>via</italic> intramembranous ossification, whereas the skull base, nasal septum, and condyle in the mandible are created <italic>via</italic> endochondral ossification (<xref ref-type="bibr" rid="bibr13-0022034512466413">Takigawa <italic>et al.</italic>, 1984</xref>; <xref ref-type="bibr" rid="bibr12-0022034512466413">Takano <italic>et al.</italic>, 1987</xref>).</p>
<p>C-type natriuretic peptide (CNP) is one of the members of the natriuretic peptide family (<xref ref-type="bibr" rid="bibr6-0022034512466413">Nakao <italic>et al</italic>., 1992</xref>). CNP exerts its biological actions through a subtype of membranous guanylyl cyclase receptor, guanylyl cyclase-B (GC-B), by elevating the intracellular cGMP production (<xref ref-type="bibr" rid="bibr11-0022034512466413">Suga <italic>et al.</italic>, 1992</xref>). We previously disclosed that the CNP/GC-B system is a potent stimulator of endochondral bone growth; both CNP and GC-B are expressed in the growth plate of long bones and vertebrae (<xref ref-type="bibr" rid="bibr2-0022034512466413">Chusho <italic>et al.</italic>, 2001</xref>), and mice lacking CNP or GC-B exhibit severely impaired growth of long bones and vertebrae (<xref ref-type="bibr" rid="bibr2-0022034512466413">Chusho <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr14-0022034512466413">Tamura <italic>et al.</italic>, 2004</xref>). In contrast, transgenic mice with targeted overexpression of CNP in growth plate cartilage or transgenic mice with increased levels of circulating CNP exhibit prominent skeletal overgrowth (<xref ref-type="bibr" rid="bibr16-0022034512466413">Yasoda <italic>et al.</italic>, 2004</xref>; <xref ref-type="bibr" rid="bibr3-0022034512466413">Kake <italic>et al</italic>., 2009</xref>).</p>
<p>Regarding the effects of CNP in the craniofacial region, previous studies in transgenic or knockout mice showed that CNP stimulates longitudinal growth of the skull (<xref ref-type="bibr" rid="bibr2-0022034512466413">Chusho <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="bibr16-0022034512466413">Yasoda <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr3-0022034512466413">Kake <italic>et al.</italic>, 2009</xref>). Nevertheless, the comprehensive effects of CNP on craniofacial skeletogenesis, including the growth of various components of the craniofacial skeleton, have not been fully elucidated. In the present study, we performed closer analyses of the effects of CNP on craniofacial skeletogenesis.</p>
</sec>
<sec id="section2-0022034512466413" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<sec id="section3-0022034512466413">
<title>Animals</title>
<p>Transgenic mice expressing CNP under the control of the mouse type II collagen promoter (<italic>Col2-Nppc-Tg</italic> mice) and CNP knockout mice (<italic>Nppc<sup>−/−</sup></italic> mice) were described previously (<xref ref-type="bibr" rid="bibr2-0022034512466413">Chusho <italic>et al.</italic>, 2001</xref>; <xref ref-type="bibr" rid="bibr16-0022034512466413">Yasoda <italic>et al.</italic>, 2004</xref>). Animal care and all experiments were conducted in accordance with the institutional guidelines of the Kyoto University Graduate School of Medicine.</p>
</sec>
<sec id="section4-0022034512466413">
<title>Imaging of Skulls</title>
<p>Skulls from adult mice were fixed in 95% ethanol. Three-dimensional reconstructions were made with microcomputed tomography (μCT, SMX-100CT-SV3, Shimadzu Co., Kyoto, Japan). The details of the methods are included in the Appendix.</p>
</sec>
<sec id="section5-0022034512466413">
<title>Soft X-ray Imaging</title>
<p>Soft x-ray analyses were performed with an SRO-M5 system (30 kVp, 5 mA for 1 min; Softron, Tokyo, Japan).</p>
</sec>
<sec id="section6-0022034512466413">
<title>Organ Culture</title>
<p>Organ culture experiments of mandibles and cranial bases from WT or <italic>Nppc<sup>−/−</sup></italic> mice at birth were performed as previously reported (<xref ref-type="bibr" rid="bibr4-0022034512466413">Lei <italic>et al.</italic>, 2008</xref>). The details of the methods are included in the Appendix.</p>
</sec>
<sec id="section7-0022034512466413">
<title>Micromass Cultures</title>
<p>The micromass culture of chondrocytes from mandibular condylar cartilage (MCC), spheno-occipital synchondrosis (SOS), or nasal septal cartilage (NSC) was performed as described in the Appendix.</p>
</sec>
<sec id="section8-0022034512466413">
<title>Histological Analysis</title>
<p>For light microscopy, sections were cut from paraffin-embedded specimens. The details of the methods, including immunohistochemical staining, are described in the Appendix.</p>
</sec>
<sec id="section9-0022034512466413">
<title>Real-time Reverse-transcription/Polymerase Chain-reaction (RT-PCR) Analyses</title>
<p>The details of the methods are included in the Appendix.</p>
</sec>
<sec id="section10-0022034512466413">
<title>Statistical Analysis</title>
<p>Data are expressed as means ± SEM. Statistical analysis was performed by analysis of variance (ANOVA) with Fisher’s least significant difference method when appropriate. <italic>P</italic> values less than 0.05 were considered statistically significant. We used a non-parametric statistical technique to evaluate the significance of differences observed with Euclidean distance matrix analysis (EDMA).</p>
</sec>
</sec>
<sec id="section11-0022034512466413" sec-type="results">
<title>Results</title>
<sec id="section12-0022034512466413">
<title>Morphologic Analyses of Skulls from CNP Mutant Mice</title>
<p>To investigate the effects of CNP on craniofacial skeletogenesis, we examined the skulls of CNP mutant mice. Gross morphologic analyses and skeletal preparations demonstrated that, compared with WT mice, the skulls of <italic>Nppc<sup>−/−</sup></italic> mice were longitudinally shorter, whereas those of <italic>Col2-Nppc-Tg</italic> mice were longer (<xref ref-type="fig" rid="fig1-0022034512466413">Figs. 1A</xref>, <xref ref-type="fig" rid="fig1-0022034512466413">1B</xref>). Further, skeletal preparations revealed shorter lower jaws in <italic>Nppc<sup>−/−</sup></italic> mice than in WT mice. In contrast, lower jaws of <italic>Col2-Nppc-Tg</italic> mice did not differ from those obtained from WT mice (<xref ref-type="fig" rid="fig1-0022034512466413">Fig. 1B</xref>).</p>
<fig id="fig1-0022034512466413" position="float">
<label>Figure 1.</label>
<caption><p>Craniofacial morphology of <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. <bold>(A)</bold> Gross morphologies of 12-week-old <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. <bold>(B)</bold> Skeletal preparations from 12-week-old <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. <bold>(C)</bold> Left: Linear measurements for analysis of normal mouse skulls. Adapted from <xref ref-type="bibr" rid="bibr9-0022034512466413">Richtsmeier <italic>et al</italic>. (2000)</xref> and the Craniofacial Resource from The Jackson Laboratory (<ext-link ext-link-type="uri" xlink:href="http://www.jax.org/cranio/index.html">www.jax.org/cranio/index.html</ext-link>). Right: Three-dimensional reconstructed images of the skulls of 12-week-old <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. <bold>(D)</bold> Linear measurements from 12-week-old <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. <bold>(E)</bold> Landmarks used for EDMA. Schematic images of the mouse cranium (upper, superior view; middle, lateral view) and mandible (lower, lateral view). Significantly smaller or larger values (n = 8, <italic>P</italic> &lt; 0.05 or 0.01) compared with those for WT mice are denoted by different lines. Blue lines show significant hypoplasia, and red lines show significant hyperplasia compared with WT mice (solid lines, <italic>p</italic> &lt; 0.01; dotted lines, <italic>p</italic> &lt; 0.05).</p></caption>
<graphic xlink:href="10.1177_0022034512466413-fig1.tif"/>
</fig>
<p>To further analyze morphologic changes in the skulls of CNP mutant mice, we performed morphometric analyses using μCT images (<xref ref-type="fig" rid="fig1-0022034512466413">Figs. 1C</xref>, <xref ref-type="fig" rid="fig1-0022034512466413">1D</xref>). Linear measurements—defined in <xref ref-type="fig" rid="fig1-0022034512466413">Fig. 1C</xref>—confirmed significantly reduced and increased skull lengths for <italic>Nppc<sup>−/−</sup></italic> crania and <italic>Col2-Nppc-Tg</italic> crania, respectively. Nose length, nasal bone length, and upper jaw length, which together comprise the skull length, were each significantly reduced in <italic>Nppc<sup>−/−</sup></italic> crania and increased in <italic>Col2-Nppc-Tg</italic> crania, compared with results from WT crania. The lower jaws of <italic>Nppc<sup>−/−</sup></italic> mice were also shorter than those of WT mice, although the phenotype was milder than those of bones that contribute to the growth of skull length. The lower jaw length of <italic>Col2-Nppc-Tg</italic> mice did not markedly differ from that of WT mice. Skull widths and inter-orbital distances were not affected by the genetic modifications.</p>
<p>Next, we investigated morphologic craniofacial changes in the mutant mice using Euclidean distance matrix analysis (EDMA) (<xref ref-type="fig" rid="fig1-0022034512466413">Fig. 1E</xref>) (<xref ref-type="bibr" rid="bibr9-0022034512466413">Richtsmeier <italic>et al.</italic>, 2000</xref>; <xref ref-type="bibr" rid="bibr1-0022034512466413">Arron <italic>et al.</italic>, 2006</xref>). The nasal, premaxilla, maxilla, and frontal bones were more markedly affected than the neurocranium, resulting in hypoplasia in <italic>Nppc<sup>−/−</sup></italic> crania or hyperplasia in <italic>Col2-Nppc-Tg</italic> crania along the sagittal plane. <italic>Nppc<sup>−/−</sup></italic> mice showed mandibular hypoplasia at the center of the condylar process and angular process in the sagittal direction. No difference in EDMA measurements was noted among the mandibles of WT and <italic>Col2-Nppc-Tg</italic> mice.</p>
</sec>
<sec id="section13-0022034512466413">
<title>Effects of CNP on the Growth of the Skull Base</title>
<p>The spheno-occipital synchondrosis (SOS) is an important growth center in the craniomaxillofacial skeleton; this structure regulates temporal and positional cues for the growth and development of the maxilla (<xref ref-type="bibr" rid="bibr10-0022034512466413">Singh, 1999</xref>; <xref ref-type="bibr" rid="bibr4-0022034512466413">Lei <italic>et al.</italic>, 2008</xref>). The longitudinal length of the skull base is defined as endochondral bone growth occurring at SOS. Because CNP is a potent stimulator of long bone and vertebral growth <italic>via</italic> endochondral ossification, we investigated the effects of CNP on endochondral bone growth in the skull base. μCT imaging showed that the skull base was shorter in <italic>Nppc<sup>−/−</sup></italic> mice and longer in <italic>Col2-Nppc-Tg</italic> mice compared with WT mice (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2A</xref>). In fact, both the occipital and sphenoid bones that comprise the skull base were significantly shorter in <italic>Nppc<sup>−/−</sup></italic> mice and longer in <italic>Col2-Nppc-Tg</italic> mice than in WT mice (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2B</xref>). Furthermore, histological examination revealed that, compared with WT skull bases, SOS was markedly narrower in the <italic>Nppc<sup>−/−</sup></italic> skull base and wider in the <italic>Col2-Nppc-Tg</italic> skull base at the ages of 2 and 4 wks (<xref ref-type="fig" rid="fig2-0022034512466413">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034512466413">2D</xref>). Immunohistochemical analysis of type X collagen—a marker of hypertrophic chondrocyte differentiation—revealed a narrower and wider hypertrophic chondrocyte layer in <italic>Nppc−</italic>/− synchondroses and <italic>Col2-Nppc-Tg</italic> synchondroses, respectively (<xref ref-type="fig" rid="fig2-0022034512466413">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034512466413">2D</xref>). In <italic>Col2-Nppc-Tg</italic> synchondroses, chondrocytes in the hypertrophic and proliferative layers were enlarged compared with cells in the WT synchondroses, especially at the age of 4 wks (<xref ref-type="fig" rid="fig2-0022034512466413">Figs. 2C</xref>, <xref ref-type="fig" rid="fig2-0022034512466413">2D</xref>). As for the expression pattern of GC-B, the receptor of CNP, in WT SOS, immunohistochemical analysis revealed that GC-B is expressed in prehypertrophic chondrocytes (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2E</xref>). Furthermore, CNP was also, but weakly, expressed in the prehypertrophic chondrocytes in WT SOS (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2E</xref>).</p>
<fig id="fig2-0022034512466413" position="float">
<label>Figure 2.</label>
<caption><p>Effects of CNP on growth of the skull base. <bold>(A)</bold> Sagittal sections from μCT images of 12-week-old <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. <bold>(B)</bold> Sagittal lengths of occipital and sphenoid bones from 12-week-old <italic>Nppc<sup>−/−</sup></italic>, WT, and <italic>Col2-Nppc-Tg</italic> mice. (<bold>C, D</bold>) Histological examination of spheno-occipital synchondrosis (SOS) from two-week-old (C) and four-week-old (D) Nppc−/−, WT, and Col2-Nppc-Tg mice. Samples were stained with Alcian blue-HE (upper, and middle with higher magnification) and immunohistochemically labeled for type X collagen (lower). <bold>(E)</bold> Immunohistochemical staining for CNP (upper) and GC-B (lower) of SOS from 2-week-old WT mice. Lower panel in each set is shown with higher magnification, and the arrowhead indicates positive staining. <bold>(F)</bold> Histological examination of SOS after a six-day organ culture and staining with Alcian blue-HE in skull base explants from fetal <italic>Nppc−/−</italic> and WT mice treated with vehicle or 10<sup>−8</sup> to 10<sup>−6</sup> M CNP. <bold>(G)</bold> Lengths of SOS from fetal WT and <italic>Nppc−/−</italic> mice at the end of six-day organ cultures. <bold>(H)</bold> Lengths of SOS from WT mice treated with vehicle or 10<sup>−8</sup>−10<sup>−6</sup> M CNP at the end of six-day organ cultures. <bold>(I)</bold> PCNA labeling index of SOS in skull base explants from fetal WT mice treated with vehicle or 10<sup>−6</sup> M CNP at the end of six-day organ culture. <bold>(J)</bold> Immunohistochemical staining for type X collagen of SOS in skull base explants from fetal <italic>Nppc−/−</italic>, WT, and WT treated with 10<sup>−7</sup> M CNP after six-day organ culture. <bold>(K)</bold> WT SOS-derived micromass cultures on day 21 were stained with Alcian blue-HE after treatment with vehicle or 10<sup>−8</sup> to 10<sup>−6</sup> M CNP. <bold>(L)</bold> Expressions of genes for aggrecan (left) and type X collagen (right) in the SOS-derived micromass cultures treated with vehicle or 10<sup>−6</sup> M CNP for 10 days, analyzed by real-time RT-PCR. All scale bars: 100 μm.</p></caption>
<graphic xlink:href="10.1177_0022034512466413-fig2.tif"/>
</fig>
<p>To further analyze the effects of CNP on endochondral bone growth at SOS, we performed organ culture experiments using skull base explants from fetal <italic>Nppc<sup>−/−</sup></italic> and WT mice. At the end of 6-day cultures, synchondroses of skull base explants from <italic>Nppc<sup>−/−</sup></italic> mice were approximately 15% shorter than those from WT mice (<xref ref-type="fig" rid="fig2-0022034512466413">Figs. 2F</xref>, <xref ref-type="fig" rid="fig2-0022034512466413">2G</xref>). In contrast, treatment of WT skull base explants with CNP significantly increased the lengths of SOS (<xref ref-type="fig" rid="fig2-0022034512466413">Figs. 2F</xref>, <xref ref-type="fig" rid="fig2-0022034512466413">2H</xref>). SOS in WT skull base explants treated with 10<sup>−8</sup> or 10<sup>−7</sup> M CNP for 6 days were approximately 30% longer than results observed in explants treated with vehicle (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2H</xref>). Moreover, chondrocytes in the CNP-treated SOS were enlarged compared with vehicle-treated chondrocytes (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2F</xref>). As for the effect of CNP on the proliferation of chondrocytes in SOS, we performed immunohistochemical staining for PCNA and found that CNP did not significantly, but tended to, increase the ratio of PCNA-positive cells (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2I</xref>). In contrast, immunohistochemical analysis of type X collagen revealed a narrower and wider hypertrophic chondrocyte layer in <italic>Nppc−/−</italic> synchondroses and WT synchondroses treated with 10<sup>−7</sup> M CNP, respectively (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2J</xref>).</p>
<p>We also studied the effects of CNP on chondrocytes from SOS using micromass cultures. CNP dose-dependently increased the micromass thickness of chondrocytes from WT SOS (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2K</xref>). The chondrocytes dose-dependently increased in size in response to CNP (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2K</xref>). Further, we analyzed expressions of chondrogenic differentiation markers of micromass using real-time RT-PCR. The expression of aggrecan, a major sulfated proteoglycan of the cartilage matrix and a highly specific marker of differentiated chondrocytes, was significantly higher in the CNP-treated group than in the vehicle-treated group (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2L</xref>). The expression of type X collagen, a specific marker for hypertrophic chondrocytes, was also significantly higher in the CNP-treated group than in the control group (<xref ref-type="fig" rid="fig2-0022034512466413">Fig. 2L</xref>).</p>
</sec>
<sec id="section14-0022034512466413">
<title>Effects of CNP on Endochondral Bone Growth from Nasal Septal Cartilage (NSC)</title>
<p>Growth of NSC is essential for longitudinal facial growth (<xref ref-type="bibr" rid="bibr15-0022034512466413">Wealthall and Herring, 2006</xref>). Because μCT analysis revealed that nasal bone length or nose length was significantly shorter in <italic>Nppc<sup>−/−</sup></italic> mice and significantly longer in <italic>Col2-Nppc-Tg</italic> mice, after confirming the expression of both CNP and GC-B in WT NSC by immunohistochemical staining (Appendix Fig.), we examined the direct effects of CNP on NSC using micromass cultures of chondrocytes from WT nasal septum. Histological sections revealed that CNP increased the thickness of the micromass, an effect that was dose-dependent (<xref ref-type="fig" rid="fig3-0022034512466413">Fig. 3A</xref>). The addition of CNP resulted in larger chondrocytes and increased extracellular space stained by Alcian blue. In real-time RT-PCR, the expressions of aggrecan and type X collagen were significantly higher in the CNP-treated group than in the vehicle-treated group (<xref ref-type="fig" rid="fig3-0022034512466413">Fig. 3B</xref>).</p>
<fig id="fig3-0022034512466413" position="float">
<label>Figure 3.</label>
<caption><p>Effects of CNP on the growth of nasal septal cartilage (NSC). <bold>(A)</bold> Histological examination of WT NSC-derived micromass cultures. Samples were treated with vehicle or 10<sup>−8</sup> to 10<sup>−6</sup> M CNP and stained on day 21 with Alcian blue-HE. <bold>(B)</bold> Expressions of genes for aggrecan (left) and type X collagen (right) in the NSC-derived micromass cultures treated with vehicle or 10<sup>−6</sup> M CNP for 10 days, analyzed by real-time RT-PCR.</p></caption>
<graphic xlink:href="10.1177_0022034512466413-fig3.tif"/>
</fig>
</sec>
<sec id="section15-0022034512466413">
<title>Effects of CNP on Mandibular Growth</title>
<p>Because morphometric analysis revealed impaired mandibular growth in <italic>Nppc<sup>−/−</sup></italic> mice, we analyzed the effect of CNP on the growth of condylar cartilage in organ cultures of fetal murine mandibular explants. The length of condylar cartilage of <italic>Nppc<sup>−/−</sup></italic> mice, measured by means of a linear ocular scale mounted on a dissecting microscope, was significantly shorter than that of wild-type mice at the end of the 6-day culture period (<xref ref-type="fig" rid="fig4-0022034512466413">Figs. 4A</xref>, <xref ref-type="fig" rid="fig4-0022034512466413">4B</xref>). Histological examination revealed that the chondrocytes in the <italic>Nppc<sup>−/−</sup></italic> condylar cartilage were smaller than those in the WT condylar cartilage, resulting in hypoplasia in the <italic>Nppc−/−</italic> explants (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4C</xref>). Furthermore, the area of hypertrophic chondrocytes in the <italic>Nppc−/−</italic> condylar cartilage was smaller than that in the WT condylar cartilage, as is observed in SOS or growth plate of long bones (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4C</xref>). In contrast, treating WT mandibular explants with CNP dose-dependently increased the length of condylar cartilage (<xref ref-type="fig" rid="fig4-0022034512466413">Figs. 4D</xref>, <xref ref-type="fig" rid="fig4-0022034512466413">4E</xref>); 10<sup>−7</sup> or 10<sup>−6</sup> M CNP significantly increased the condylar cartilage length (<italic>p</italic> &lt; 0.05, n = 5 for each group) (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4E</xref>). Not only each chondrocyte but also the area of hypertrophic chondrocytes in the condylar cartilage was enlarged when CNP was supplied to the culture (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4F</xref>). In fact, immunohistochemical study revealed that both GC-B and CNP were expressed in the prehypertrophic chondrocytes in WT condylar cartilage (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4G</xref>).</p>
<fig id="fig4-0022034512466413" position="float">
<label>Figure 4.</label>
<caption><p>Effects of CNP on mandibular growth. <bold>(A)</bold> Mandibular explants from fetal WT and <italic>Nppc<sup>−/−</sup></italic> mice were stained with Alcian blue and Alizarin red after six-day organ cultures. <bold>(B)</bold> Lengths of MCC from fetal WT and <italic>Nppc<sup>−/−</sup></italic> mice after a six-day organ culture. <bold>(C)</bold> Histological analysis of mandibular condylar cartilage (MCC) stained with Alcian blue-HE after six-day organ cultures with mandibular explants from fetal WT and <italic>Nppc<sup>−/−</sup></italic> mice. Right panel in each set of panels is exhibited with higher magnification. <bold>(D)</bold> Mandibular explants from fetal WT mice were treated with vehicle or CNP 10<sup>−7</sup> M in six-day organ cultures and stained with Alcian blue and Alizarin red. <bold>(E)</bold> Lengths of MCC from WT mice treated with vehicle or 10<sup>−8</sup> to10<sup>−6</sup> M CNP in six-day organ cultures. <bold>(F)</bold> Histological examination of MCC six-day organ cultures and staining with Alcian blue-HE. Fetal WT murine mandibular explants were treated with vehicle or CNP 10<sup>−7</sup> M. <bold>(G)</bold> Immunohistochemical staining for CNP (left set) and GC-B (right set) of MCC from two-week-old WT mice. Right panel in each set is exhibited with higher magnification. <bold>(H)</bold> Histological examination of WT MCC-derived micromass cultures treated with vehicle or 10<sup>−8</sup> to 10<sup>−6</sup> M CNP and stained with Alcian blue-HE on day 21. <bold>(I)</bold> Expressions of genes for aggrecan (left) and type X collagen (right) in the MCC-derived micromass cultures treated with vehicle or 10<sup>−6</sup> M CNP for 10 days, analyzed by real-time RT-PCR. All scale bars: 100 μm.</p></caption>
<graphic xlink:href="10.1177_0022034512466413-fig4.tif"/>
</fig>
<p>To further elucidate the effects of CNP on condylar cartilage, we examined micromass cultures of chondrocytes from WT condylar cartilage. Histological sections showed that CNP dose-dependently increased the thickness of the micromass cultures (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4H</xref>). CNP increased the sizes of the chondrocytes in the micromass, and the extracellular space stained by Alcian blue (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4H</xref>). In real-time RT-PCR, the expressions of aggrecan and type X collagen were significantly higher in the CNP-treated group than in the vehicle-treated group (<xref ref-type="fig" rid="fig4-0022034512466413">Fig. 4I</xref>).</p>
</sec>
</sec>
<sec id="section16-0022034512466413" sec-type="discussion">
<title>Discussion</title>
<p>In the present study, we investigated the effects of CNP on craniofacial skeletogenesis. Craniofacial skeletogenesis consists of both endochondral and membranous ossification (<xref ref-type="bibr" rid="bibr7-0022034512466413">Nie <italic>et al</italic>., 2006</xref>). Morphometric analyses of <italic>Nppc<sup>−/−</sup></italic> and <italic>Col2-Nppc-Tg</italic> mice by μCT images clearly demonstrated that CNP affects longitudinal skull growth. Because longitudinal skull growth mainly depends on endochondral bone growth of the skull base at SOS and of the nasal septum, these results indicate that CNP stimulates endochondral bone growth during craniofacial skeletogenesis. Furthermore, using organ and micromass cultures, we demonstrated that CNP stimulates endochondral bone growth in the skull base and nasal septum. Of note, these results agreed with those from our previous study showing that CNP is a potent stimulator of the endochondral ossification-based growth of long bones and vertebrae (<xref ref-type="bibr" rid="bibr16-0022034512466413">Yasoda <italic>et al</italic>., 2004</xref>). Actually, histological analyses revealed that the morphological alterations of SOS in <italic>Nppc−/−</italic> and <italic>Col2-Nppc-Tg</italic> mice compared with those in WT mice are the same as those observed in growth plates of long bones in <italic>Nppc−/−</italic> and <italic>Col2-Nppc-Tg</italic> mice, respectively.</p>
<p>As for the lower jaw, mandibular development depends on endochondral and membranous ossification. Specifically, endochondral ossification contributes to the formation of condylar cartilage, whereas the mandibular body forms <italic>via</italic> membranous ossification (<xref ref-type="bibr" rid="bibr8-0022034512466413">Oka <italic>et al</italic>., 2007</xref>). Although we confirmed the stimulatory effects of CNP on endochondral bone growth in condylar cartilage using organ and micromass culture experiments, morphometric analyses revealed that the impaired growth of the lower jaw was weaker than the upper jaw phenotype in <italic>Nppc<sup>−/−</sup></italic> mice, and lower jaws of <italic>Col2-Nppc-Tg</italic> mice were not affected. These results indicated that the stimulatory effects of CNP on bone growth were weaker in the mandible compared with the skull base. The reason might be that the mandible does not grow by primarily endochondral ossification. During development, bones of the mandible undergo intramembranous ossification surrounding Meckel’s cartilage. The condylar cartilage makes up the mandibular portion of the temporomandibular joint. Differential growth of the condylar cartilage may make the mandible seem larger, but that might be due to displacement in the joint, rather than mandibular growth. Conversely, mandibular hypoplasia of <italic>Nppc−/−</italic> mice might be due to disturbed growth caused by malocclusion. This may explain why the <italic>Col2-Nppc-Tg</italic> mandibles are the same length as WT mandibles.</p>
<p>In conclusion, we investigated the effects of CNP on craniofacial skeletogenesis. CNP is a pivotal stimulator of endochondral bone growth in the craniofacial region, and plays an important role in midfacial skeletogenesis.</p>
</sec>
</body>
<back>
<ack><p>We thank B. de Crombrugghe (Department of Genetics, University of Texas M. D. Anderson Cancer Center) for the Col2a1 promoter.</p></ack>
<fn-group>
<fn fn-type="supplementary-material">
<p>A supplemental appendix to this article is published electronically only at <ext-link ext-link-type="uri" xlink:href="http://jdr.sagepub.com/supplemental">http://jdr.sagepub.com/supplemental</ext-link>.</p>
</fn>
<fn fn-type="supported-by">
<p>This work was supported by Grants-in-Aid for <grant-sponsor>Scientific Research from the Ministry of Health, Labour and Welfare of Japan and the Ministry of Education, Culture, Sports, Science and Technology of Japan</grant-sponsor> (<grant-num>#19591075</grant-num>, <grant-num>21591176</grant-num>, <grant-num>21119013</grant-num>, and <grant-num>21390533</grant-num>).</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arron</surname><given-names>JR</given-names></name>
<name><surname>Winslow</surname><given-names>MM</given-names></name>
<name><surname>Polleri</surname><given-names>A</given-names></name>
<name><surname>Chang</surname><given-names>CP</given-names></name>
<name><surname>Wu</surname><given-names>H</given-names></name>
<name><surname>Gao</surname><given-names>X</given-names></name>
<etal/></person-group>. (<year>2006</year>). <article-title>NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21</article-title>. <source>Nature</source> <volume>441</volume>:<fpage>595</fpage>-<lpage>600</lpage>.</citation>
</ref>
<ref id="bibr2-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chusho</surname><given-names>H</given-names></name>
<name><surname>Tamura</surname><given-names>N</given-names></name>
<name><surname>Ogawa</surname><given-names>Y</given-names></name>
<name><surname>Yasoda</surname><given-names>A</given-names></name>
<name><surname>Suda</surname><given-names>M</given-names></name>
<name><surname>Miyazawa</surname><given-names>T</given-names></name>
<etal/></person-group>. (<year>2001</year>). <article-title>Dwarfism and early death in mice lacking C-type natriuretic peptide</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>98</volume>:<fpage>4016</fpage>-<lpage>4021</lpage>.</citation>
</ref>
<ref id="bibr3-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kake</surname><given-names>T</given-names></name>
<name><surname>Kitamura</surname><given-names>H</given-names></name>
<name><surname>Adachi</surname><given-names>Y</given-names></name>
<name><surname>Yoshioka</surname><given-names>T</given-names></name>
<name><surname>Watanabe</surname><given-names>T</given-names></name>
<name><surname>Matsushita</surname><given-names>H</given-names></name>
<etal/></person-group>. (<year>2009</year>). <article-title>Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice</article-title>. <source>Am J Physiol Endocrinol Metab</source> <volume>297</volume>:<fpage>E1339</fpage>-<lpage>E1348</lpage>.</citation>
</ref>
<ref id="bibr4-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lei</surname><given-names>WY</given-names></name>
<name><surname>Wong</surname><given-names>RW</given-names></name>
<name><surname>Rabie</surname><given-names>AB</given-names></name>
</person-group> (<year>2008</year>). <article-title>Factors regulating endochondral ossification in the spheno-occipital synchondrosis</article-title>. <source>Angle Orthod</source> <volume>78</volume>:<fpage>215</fpage>-<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr5-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lenton</surname><given-names>K</given-names></name>
<name><surname>James</surname><given-names>AW</given-names></name>
<name><surname>Manu</surname><given-names>A</given-names></name>
<name><surname>Brugmann</surname><given-names>SA</given-names></name>
<name><surname>Birker</surname><given-names>D</given-names></name>
<name><surname>Nelson</surname><given-names>ER</given-names></name>
<etal/></person-group>. (<year>2011</year>). <article-title>Indian hedgehog positively regulates calvarial ossification and modulates bone morphogenetic protein signaling</article-title>. <source>Genesis</source> <volume>49</volume>:<fpage>784</fpage>-<lpage>796</lpage>.</citation>
</ref>
<ref id="bibr6-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakao</surname><given-names>K</given-names></name>
<name><surname>Ogawa</surname><given-names>Y</given-names></name>
<name><surname>Suga</surname><given-names>S</given-names></name>
<name><surname>Imura</surname><given-names>H</given-names></name>
</person-group> (<year>1992</year>). <article-title>Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides</article-title>. <source>J Hypertens</source> <volume>10</volume>:<fpage>907</fpage>-<lpage>912</lpage>.</citation>
</ref>
<ref id="bibr7-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nie</surname><given-names>X</given-names></name>
<name><surname>Luukko</surname><given-names>K</given-names></name>
<name><surname>Kettunen</surname><given-names>P</given-names></name>
</person-group> (<year>2006</year>). <article-title>BMP signalling in craniofacial development</article-title>. <source>Int J Dev Biol</source> <volume>50</volume>:<fpage>511</fpage>-<lpage>521</lpage>.</citation>
</ref>
<ref id="bibr8-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oka</surname><given-names>K</given-names></name>
<name><surname>Oka</surname><given-names>S</given-names></name>
<name><surname>Sasaki</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>Y</given-names></name>
<name><surname>Bringas</surname><given-names>P</given-names><suffix>Jr</suffix></name>
<name><surname>Nonaka</surname><given-names>K</given-names></name>
<etal/></person-group>. (<year>2007</year>). <article-title>The role of TGF-beta signaling in regulating chondrogenesis and osteogenesis during mandibular development</article-title>. <source>Dev Biol</source> <volume>303</volume>:<fpage>391</fpage>-<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr9-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richtsmeier</surname><given-names>JT</given-names></name>
<name><surname>Baxter</surname><given-names>LL</given-names></name>
<name><surname>Reeves</surname><given-names>RH</given-names></name>
</person-group> (<year>2000</year>). <article-title>Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice</article-title>. <source>Dev Dyn</source> <volume>217</volume>:<fpage>137</fpage>-<lpage>145</lpage>.</citation>
</ref>
<ref id="bibr10-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>GD</given-names></name>
</person-group> (<year>1999</year>). <article-title>Morphologic determinants in the etiology of class III malocclusions: a review</article-title>. <source>Clin Anat</source> <volume>12</volume>:<fpage>382</fpage>-<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr11-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suga</surname><given-names>S</given-names></name>
<name><surname>Nakao</surname><given-names>K</given-names></name>
<name><surname>Hosoda</surname><given-names>K</given-names></name>
<name><surname>Mukoyama</surname><given-names>M</given-names></name>
<name><surname>Ogawa</surname><given-names>Y</given-names></name>
<name><surname>Shirakami</surname><given-names>G</given-names></name>
<etal/></person-group>. (<year>1992</year>). <article-title>Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide</article-title>. <source>Endocrinology</source> <volume>130</volume>:<fpage>229</fpage>-<lpage>239</lpage>.</citation>
</ref>
<ref id="bibr12-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takano</surname><given-names>T</given-names></name>
<name><surname>Takigawa</surname><given-names>M</given-names></name>
<name><surname>Shirai</surname><given-names>E</given-names></name>
<name><surname>Nakagawa</surname><given-names>K</given-names></name>
<name><surname>Sakuda</surname><given-names>M</given-names></name>
<name><surname>Suzuki</surname><given-names>F</given-names></name>
</person-group> (<year>1987</year>). <article-title>The effect of parathyroid hormone (1-34) on cyclic AMP level, ornithine decarboxylase activity, and glycosaminoglycan synthesis of chondrocytes from mandibular condylar cartilage, nasal septal cartilage, and spheno-occipital synchondrosis in culture</article-title>. <source>J Dent Res</source> <volume>66</volume>:<fpage>84</fpage>-<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr13-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takigawa</surname><given-names>M</given-names></name>
<name><surname>Okada</surname><given-names>M</given-names></name>
<name><surname>Takano</surname><given-names>T</given-names></name>
<name><surname>Ohmae</surname><given-names>H</given-names></name>
<name><surname>Sakuda</surname><given-names>M</given-names></name>
<name><surname>Suzuki</surname><given-names>F</given-names></name>
</person-group> (<year>1984</year>). <article-title>Studies on chondrocytes from mandibular condylar cartilage, nasal septal cartilage, and spheno-occipital synchondrosis in culture. I. Morphology, growth, glycosaminoglycan synthesis, and responsiveness to bovine parathyroid hormone (1-34)</article-title>. <source>J Dent Res</source> <volume>63</volume>:<fpage>19</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr14-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tamura</surname><given-names>N</given-names></name>
<name><surname>Doolittle</surname><given-names>LK</given-names></name>
<name><surname>Hammer</surname><given-names>RE</given-names></name>
<name><surname>Shelton</surname><given-names>JM</given-names></name>
<name><surname>Richardson</surname><given-names>JA</given-names></name>
<name><surname>Garbers</surname><given-names>DL</given-names></name>
</person-group> (<year>2004</year>). <article-title>Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>101</volume>:<fpage>17300</fpage>-<lpage>17305</lpage>.</citation>
</ref>
<ref id="bibr15-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wealthall</surname><given-names>RJ</given-names></name>
<name><surname>Herring</surname><given-names>SW</given-names></name>
</person-group> (<year>2006</year>). <article-title>Endochondral ossification of the mouse nasal septum</article-title>. <source>Anat Rec A Discov Mol Cell Evol Biol</source> <volume>288</volume>:<fpage>1163</fpage>-<lpage>1172</lpage>.</citation>
</ref>
<ref id="bibr16-0022034512466413">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yasoda</surname><given-names>A</given-names></name>
<name><surname>Komatsu</surname><given-names>Y</given-names></name>
<name><surname>Chusho</surname><given-names>H</given-names></name>
<name><surname>Miyazawa</surname><given-names>T</given-names></name>
<name><surname>Ozasa</surname><given-names>A</given-names></name>
<name><surname>Miura</surname><given-names>M</given-names></name>
<etal/></person-group>. (<year>2004</year>). <article-title>Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway</article-title>. <source>Nat Med</source> <volume>10</volume>:<fpage>80</fpage>-<lpage>86</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>